AON PLC A DL -,01/ IE00BLP1HW54 /
2024-06-13 9:55:32 AM | Chg. +0.60 | Volume | Bid9:55:32 AM | Ask9:55:32 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
271.30EUR | +0.22% | - Turnover: - |
271.30Bid Size: - | 273.90Ask Size: - | 122.55 bill.EUR | - | - |
GlobeNewswire
06-10
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
06-04
American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting
GlobeNewswire
06-03
American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer
GlobeNewswire
05-30
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of D...
GlobeNewswire
05-15
American Oncology Network Advances Karyogram Segmentation and Increases the Speed to Results with Ne...
GlobeNewswire
05-14
American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Con...
GlobeNewswire
05-14
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
GlobeNewswire
05-08
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 ...
GlobeNewswire
04-30
American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call
GlobeNewswire
04-25
American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in...